2025 and Vaccines - Pharmacy Technician Pulse

Q&A: Pharmacist Highlights Challenges in Vaccine Information Navigation Amid Changing Recommendations

Drug Topics

JULY 2, 2025

In an interview, Cherokee Layson-Wolf, PharmD, BCACP, FAPhA, professor of practice, sciences, and health outcomes research at the University of Maryland, explored the evolving landscape of vaccine recommendations, emphasizing the critical role pharmacists play in guiding patients through complex medical information.

Vaccines

Vaccines Immunization Compounding Communication

Pneumococcal Vaccine Rates Low Despite Updated Recommendations

Drug Topics

JULY 11, 2025

In 2022, the Advisory Committee on Immunization Practices (ACIP) published updated pneumococcal vaccine recommendations. In 2022, the Advisory Committee on Immunization Practices (ACIP) published updated pneumococcal vaccine recommendations. Of those, 38% had evidence of pneumococcal vaccination prior to January 2022.

Vaccines

Vaccines Immunization Specialty Pharmacies Compounding

Q&A: Expert Highlights Importance of Trusted Sources for Vaccine Information

Drug Topics

JULY 6, 2025

In an interview on vaccine recommendations, health care professionals expressed growing concerns about the changing landscape of medical information dissemination. Health care professionals emphasize patient education and reliable information in the evolving vaccine recommendation landscape.

Vaccines

Vaccines Immunization Insurance Communication

Passport to Protection: Best Practices for Travel Vaccines in the Pharmacy Setting

Drug Topics

JUNE 6, 2025

Garofoli, PharmD, BCACP, CTTS, FAPhA Publication Article Drug Topics Journal Drug Topics May/June 2025 Volume 169 Issue 03 Pharmacy team members can help patients prepare for upcoming travels, ensuring they are up to date with the recommended vaccines for their locations. The first resource is the CDC’s Yellow Book.

Vaccines

Vaccines Immunization Specialty Pharmacies Compounding

Pneumococcal Vaccine Patient Education: What Pharmacists Should Know and Share

Drug Topics

JULY 14, 2025

Panelists discuss how pharmacists should educate patients about pneumococcal vaccines by providing current vaccine information statements (VIS) updated May 29, 2025, explaining common adverse effects like injection site reactions and mild systemic symptoms as normal immune responses, conducting thorough pre-vaccination screening for moderate-to-severe (..)

Vaccines

Vaccines Communication Immunization

ACIP Panel Removal Sparks Concerns, Pharmacists Warn of More Vaccine Distrust

Drug Topics

JUNE 20, 2025

Experts discuss the recent dismissal of all 17 members of the Advisory Committee on Immunization Practices (ACIP), a panel that provides guidance to the CDC on vaccine recommendations. This abrupt change has raised significant concerns within the health care community about the potential impact on vaccine trust and public health policy.

Vaccines

Vaccines Immunization Specialty Pharmacies Compounding

As its cancer vaccine moves through the clinic, Transgene sets sights on manufacturing

PharmaVoice

JULY 9, 2025

Published July 9, 2025 Amy Baxter Staff Reporter post share post print email license Stock via Getty Images Listen to the article 6 min This audio is auto-generated. Cancer vaccine efficacy Transgene is taking aim at early-stage cancers with virus-based therapies targeting neoantigens on tumors.

Vaccines

Vaccines Immunization

Flu Vaccines Are a Go

Pharmacy Times

JULY 16, 2025

The shift away from thimerosal may increase the use of single-dose syringes, impacting vaccination practices in various healthcare settings. The shift away from thimerosal may increase the use of single-dose syringes, impacting vaccination practices in various healthcare settings.

Vaccines

Vaccines Community Pharmacies Immunization Compounding Pharmacies

COVID-19 Pandemic Reduced Gaps in Pneumococcal Vaccination in Medicare Enrollees, But Lowered Overall Uptake

Pharmacy Times

JULY 25, 2025

Increased awareness of infectious diseases during the pandemic may have improved vaccine uptake among Medicare enrollees, while service reductions and vaccine hesitancy affected Medicaid enrollees.

Vaccines

Vaccines Compounding Pharmacies Immunization Compounding

Sanofi $1.6 billion acquisition to advance respiratory vaccines

European Pharmaceutical Review

JULY 22, 2025

billion, supporting the advancement of respiratory virus vaccines. The deal intends to expand capabilities in vaccine design and development and will enable Sanofi to add a non-mRNA vaccine to its development pipeline. billion acquisition to advance respiratory vaccines appeared first on European Pharmaceutical Review.

Vaccines

Vaccines Immunization

Expanding Pneumococcal Vaccinations to Healthy Adults Aged 50 to 64 Years Offers Significant Health, Economic Benefits

Pharmacy Times

JUNE 20, 2025

Expanding use of the 15-valent pneumococcal conjugate vaccine (PCV15) or 20-valent pneumococcal conjugate vaccine (PCV20) to all United States adults aged 50 to 64 years would result in modest budget increases over a 3-year period. 1,2 A particular disease burden is present for Black Americans.

Vaccines

Vaccines Compounding Pharmacies Immunization Hospitals

Ovagen breakthrough boosts yellow fever vaccine yields

Pharma Times

JULY 23, 2025

Dr Catherine Caulfield, CEO of Ovagen said: “What we have developed isn’t incremental, it’s a complete rethink of the vaccine manufacturing process. Our germ free egg platform eliminates bacterial contamination and reduces the need for antibiotics in vaccine production, while delivering significantly higher viral yield.

Vaccines

Bharat Biotech acquires licence for GSK’s Shigella vaccine development

Pharmaceutical Technology

JUNE 13, 2025

June 13, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook GSK’s vaccine leverages GMMA technology. June 13, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook GSK’s vaccine leverages GMMA technology. Credit: viewimage/Shutterstock.

Vaccines

Vaccines Communication Hospitals Packaging

Osivax reaches key milestone in phase 2a trial for broad-spectrum flu vaccine

Pharmafile

JUNE 6, 2025

Osivax has announced the completion of patient visits in its phase 2a trial evaluating a booster dose of OVX836, a broad-spectrum influenza A vaccine candidate. The final results from the trial are expected in the second half of 2025.

Vaccines

Vaccines Hospitals

Osivax publishes phase 2a results supporting dual flu vaccine approach

Pharma Times

JULY 10, 2025

The results, now published in Vaccines , show that the combination was well-tolerated with no serious adverse events, and generated strong immune responses. The results, now published in Vaccines , show that the combination was well-tolerated with no serious adverse events, and generated strong immune responses.

Vaccines

Vaccines Immunization

Small Guillain-Barré risk after RSV vaccination in older adults, warns MHRA

Hospital Pharmacy Europe

JULY 14, 2025

Healthcare professionals have been urged to be alert for a small increased risk of Guillain-Barré syndrome following respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older. million doses of Abrysvo have been given as part of the older adult RSV vaccination programme. So far, around 1.9

Vaccines

Vaccines Hospitals

FDA Approves GSK’s Shingles Vaccine in Prefilled Syringe

Drug Topics

JULY 18, 2025

The FDA has approved a prefilled syringe format of the recombinant zoster vaccine Shingrix for the prevention of shingles, GSK said in a release. 1 The company said approval of the new presentation was based on data that showed comparability between the new and existing version of the vaccine.

Vaccines

Vaccines FDA Specialty Pharmacies Independent Pharmacies

Q&A: Pharmacies Grapple With Patient Influx Amid Rite Aid Closures

Drug Topics

JULY 1, 2025

Once the 351 Rite Aid pharmacies in Pennsylvania finally close in 2025, that will be over 600 pharmacies in Pennsylvania that closed in the last 2 years. Reimbursements are a lot better in vaccines than it is in just filling scripts. That is a real problem. We are now at the tipping point, if not beyond the tipping point.

Health and Personal Care Stores

Health and Personal Care Stores Independent Pharmacies Grocery Stores Insurance

Conference Coverage Recap: American Pharmacists Association Annual Meeting and Exposition 2025

Drug Topics

JUNE 23, 2025

Experts Debate Diabetes Care in Community Pharmacy vs Health Systems Despite evidence of improved diabetes outcomes, all pharmacy settings are capable of having a significant impact on diabetes care, according to a presentation at the American Pharmacists Association (APhA) 2025 Annual Meeting and Exposition.

Community Pharmacies

Community Pharmacies Specialty Pharmacies Compounding Independent Pharmacies

DoH – Abu Dhabi and Sanofi link for vaccine development

Pharmaceutical Technology

JUNE 20, 2025

June 20, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The MoU was signed at the BIO International Convention 2025 in Boston, US. The MoU was signed at the BIO International Convention 2025 in Boston, in the US state of Massachusetts. Credit: Department of Health Abu Dhabi.

Vaccines

Vaccines Communication Hospitals Packaging

Insights From ASCO 2025 Guide Pharmacy Practice in Solid Tumors and Hematologic Cancers

Pharmacy Times

JULY 16, 2025

The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, showcased significant advances across a range of malignancies, with novel agents, biomarker-driven strategies, and long-term outcomes data offering new insights into cancer treatment with implications for pharmacy practice.

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Compounding Pharmacies Immunization Chemotherapy

ACIP Votes Against Thimerosal Vaccines for Prevention of Influenza

Drug Topics

JUNE 27, 2025

In a vote of 5 to 1 on Thursday, members of the Advisory Committee on Immunization Practices (ACIP) voted to recommend against influenza vaccine containing the preservative thimerosal. The recommendations include all US adults as well as recommending pregnant women also receive a thimerosal-free vaccine for influenza.

Vaccines

Vaccines Independent Pharmacies Immunization Compounding

Pharmacists Can Simplify the Vaccine Schedule

Pharmacy Times

JULY 22, 2025

RSV vaccines are recommended for older adults and those with specific health conditions, with options like Arexvy, mResvia, and Abrysvo available. RSV vaccines are recommended for older adults and those with specific health conditions, with options like Arexvy, mResvia, and Abrysvo available.

Vaccines

Vaccines Immunization Compounding Pharmacies FDA

Efficiency, Education, and Evolution: What’s Next for Pharmacy Practice?

Pharmacy Times

JUNE 24, 2025

Soefje, PharmD, MBA, BCOP, FCCP, FHOPA Scott Soefje, PharmD, MBA, BCOP, shares insights about the evolving role of pharmacists at the 2025 OPC meeting. Pharmacy Times : Can you share an overview of what you discussed at OPC 2025? Author(s): Alexandra Gerlach, Associate Editor , Scott A.

Compounding Pharmacies

Compounding Pharmacies Immunization Mayo Clinic Hospitals

Shaping Pharmacy Research With Purpose and Public Impact

Pharmacy Times

JULY 22, 2025

Finerenone and the Future of Diabetes-Related Kidney Care Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Subscribe Now!

Compounding Pharmacies

Compounding Pharmacies Compounding Immunization Hospitals

PharmaShots Weekly Snapshots (Jun 09, 2025 – Jun 13, 2025) 

PharmaShots

JUNE 13, 2025

Check out our full report below:  Apellis Pharmaceuticals and Sobi Report P-III (VALIANT) Trial Data of Empaveli for C3 Glomerulopathy (C3G) and Primary IC-MPGN Read More: Apellis Pharmaceuticals and Sobi Daiichi Sankyo Reports First Patient Dosing in P-III (DESTINY-Endometrial01) Study Evaluating ENHERTU Read More: Daiichi Sankyo Regeneron Highlights (..)

FDA

FDA Vaccines

Q&A: Supporting Pharmacy Technicians Through Daily Recognition

Drug Topics

JUNE 23, 2025

Pharmacy Technicians Could Enhance Public Health by Becoming ‘Vaccine Champions’ Killian Meara October 3rd 2024 Article Researchers suggest that vaccine champion programs could be a promising avenue to increasing immunization rates.

Health and Personal Care Stores

Health and Personal Care Stores CPhT Immunization Vaccines

Independent Pharmacy Innovation Spotlighted at McKesson ideaShare 2025

Pharmacy Times

JULY 14, 2025

McKesson ideaShare 2025 brought thousands of independent pharmacists, pharmacy owners, technicians, and industry leaders together in Nashville, Tennessee, shining a spotlight on innovation and advocacy in community pharmacy. Topics included innovative clinical services , vaccine access , and the interaction of pharmacology and nutrition.

Independent Pharmacies

Independent Pharmacies Compounding Pharmacies Patient Care Hospitals

FDA Approves Vancomycin Injection For Ready-to-Infuse Sepsis Therapy

Pharmacy Times

JULY 2, 2025

July 2, 2025. Accessed July 2, 2025. Accessed July 2, 2025. Updated May 12, 2025. Accessed July 2, 2025. Hikma receives FDA approval for TYZAVANTM (Vancomycin Injection, USP) in the US. News release. Cleveland Clinic. Septicemia. News release. Updated May 17, 2021. Cleveland Clinic. Endocarditis. News release.

FDA

FDA Compounding Pharmacies Compounding Hospitals

Pharmacists Help Patients Manage Chronic Pain

Drug Topics

JUNE 8, 2025

The Current State Of OTC Medication Use for Pain Management Brian Nowosielski ; Mark Garofoli, PharmD, BCGP, CPE, CTTS April 24th 2025 Podcast Leveraging his expertise in pain management, Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, joined Drug Topics to discuss the importance of pharmacists in patients’ use of OTC medications to treat pain.

Independent Pharmacies

Independent Pharmacies Community Pharmacies Compounding Vaccines

Pharmacist-Led Interventions Show Promise in Improving COPD Outcomes

Drug Topics

JULY 17, 2025

2025; [link] 2. Accessed July 17, 2025. Accessed July 17, 2025. Dupilumab Shows Superiority Over Omalizumab for Chronic Rhinosinusitis Ashley Gallagher June 16th 2025 Article This study is the first to compare 2 biologics for patients with chronic rhinosinusitis with nasal polyps and coexisting asthma. Med Princ Pract.

Specialty Pharmacies

Specialty Pharmacies Mayo Clinic Patient Care Compounding

Inside the Synergy Between HOPA and OPC’s Evolving Educational Impact

Pharmacy Times

JUNE 20, 2025

Pharmacy Times : Can you share your experience at OPC 2025 and the significance of these meetings for pharmacists? Related Videos Related Content Advertisement June 20th 2025 Unicorns Don’t Exist: Rethinking the Generalist Model in Oncology Pharmacy Kelley D. Sessions : Oncology Pharmacists Connect—this is the third year, right?

Compounding Pharmacies

Compounding Pharmacies Immunization Specialty Pharmacies Compounding

Dapagliflozin Improves Health Outcomes for Adolescents With Type 1 Diabetes

Drug Topics

JUNE 19, 2025

June 17, 2025. Accessed June 18, 2025. Accessed June 18, 2025. Accessed June 18, 2025. Published online June 6, 2025. The Hospital For Sick Children. Type 1 diabetes. October 18, 2016. Adolescent Type 1 Diabetes Treatment With SGLT2i for hyperglycEMia & hyPerfilTration Trial (ATTEMPT).

Compounding

Compounding Vaccines Specialty Pharmacies Hospitals

Pharmacists Push Forward: Innovative Clinical Solutions Highlighted at McKesson ideaShare 2025

Pharmacy Times

JULY 12, 2025

At McKesson ideaShare 2025, pharmacy leaders spotlighted the growing role of pharmacists in expanding clinical services, including telehealth, contraception prescribing, naloxone access, and point-of-care testing (POCT). Presented at: McKesson ideaShare 2025. Nashville, TN; July 11, 2025. Accessed July 11, 2025.

Independent Pharmacies

Independent Pharmacies Hospitals Compounding Pharmacies Immunization

Pharmacists Reimagine Myeloma Care With Insights from ASCO

Pharmacy Times

JUNE 24, 2025

In an interview with Pharmacy Times® , Gabe Hinojosa, PharmD, BCOP, clinical pharmacy specialist oncology/hematology at UT Southwestern, discussed the evolving treatment landscape for multiple myeloma (MM) and presented data from the 2025 American Society of Clinical Oncology Annual Meeting (ASCO). Accessed June 24, 2025.

Compounding Pharmacies

Compounding Pharmacies Immunization Hospitals Compounding

FDA Moving to Nonanimal Testing Methodologies in Preclinical Research

Pharmacy Times

JULY 22, 2025

2 In April 2025, the FDA announced its plan to phase out the animal testing requirements and require new approach methodologies (NAMs) in early research to streamline which treatments will be safe and effective in humans, reduce drug development costs and timelines, and reduce testing in animals. Accessed June 19, 2025. April 10, 2025.

FDA

FDA Compounding Immunization Compounding Pharmacies

The Changing Landscape of Pharmacy Accessibility

Pharmacy Times

JULY 22, 2025

These deserts reduce access to critical health care services, such as vaccinations, health screenings, and point-of-care testing. The lack of access to immunization services may lead to lower vaccination rates and vulnerabilities to infectious diseases in these communities. March 17, 2025. Accessed June 4, 2025.

Mail-Order Pharmacies

Mail-Order Pharmacies Community Pharmacies Compounding Pharmacies Immunization

Creating Space for Pharmacy Technicians to Lead and Thrive

Drug Topics

JUNE 19, 2025

Recent Videos Related Content Pharmacy Technicians Could Enhance Public Health by Becoming ‘Vaccine Champions’ Killian Meara October 3rd 2024 Article Researchers suggest that vaccine champion programs could be a promising avenue to increasing immunization rates.

CPhT

CPhT Independent Pharmacies Immunization Vaccines

New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma

Pharmacy Times

JUNE 27, 2025

On January 16, 2025, the FDA approved acalabrutinib (Calquence; AstraZeneca) in combination with bendamustine and rituximab for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL) who are ineligible for autologous hematopoietic stem cell transplantation (HSCT). January 16, 2025. Cancer Treat Rev.

FDA

FDA Compounding Pharmacies Immunization Chemotherapy

Neoadjuvant Nivolumab With Chemotherapy Yields Significant Overall Survival Benefit in Resectable NSCLC

Pharmacy Times

JUNE 9, 2025

These conclusions were presented as part of an abstract from the open-label, phase 3 CheckMate 816 trial (NCT02998528) at the 2025 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois, and subsequently published in the Journal of Clinical Oncology. Last Updated January 24, 2025. Accessed June 9, 2025.

Chemotherapy

Chemotherapy Compounding Pharmacies Immunization Specialty Pharmacies

Under the Weather: Unpacking the Impact of the 2024-2025 Influenza Season

Pharmacy Times

JULY 21, 2025

Fournier, BSc Key Takeaways The 2024-2025 influenza season saw unprecedented severity, with high hospitalization and outpatient visit rates due to a vaccine mismatch and dominant H1N1 and H3N2 strains. Targeted public health strategies are needed to improve vaccine access, education, and trust, particularly in underserved communities.

Vaccines

Vaccines Immunization Hospitals Compounding Pharmacies

Q&A: How ACIP Changes Could Reshape Patient Care

Drug Topics

JULY 5, 2025

Kevin Cleveland, PharmD, professor at Idaho State University, explores the potential impacts of changes to the Advisory Committee on Immunization Practices (ACIP), highlighting concerns about shifting medical guidance and vaccine recommendations. Cleveland: So I'll start as a provider.

Patient Care

Patient Care Vaccines Insurance Immunization

ICH Q6B for Analytics

PharmTech

JUNE 6, 2025

A magnifying glass examining a vintage vaccine vial surrounded by four minimalistic chart icons, symbolizing healthcare, medicine, and analytics in the context of global health monitoring. Biosimilars continue to build as a sector of this market with an estimated 2025 value in the region of US$42 billion (1). Specifications.

Dosage

Dosage Documentation Labelling FDA

Supporting the Well-Being of Community Pharmacy Technicians

Drug Topics

JUNE 17, 2025

2025 May 9:102419. Related Content Pharmacy Technicians Could Enhance Public Health by Becoming ‘Vaccine Champions’ Killian Meara October 3rd 2024 Article Researchers suggest that vaccine champion programs could be a promising avenue to increasing immunization rates. J Am Pharm Assoc (2003). doi: 10.1016/j.japh.2025.102419.

Community Pharmacies

Community Pharmacies CPhT Immunization Vaccines

Q&A: Pharmacist Highlights Challenges in Vaccine Information Navigation Amid Changing Recommendations

Pneumococcal Vaccine Rates Low Despite Updated Recommendations

Trending Sources

Q&A: Expert Highlights Importance of Trusted Sources for Vaccine Information

Passport to Protection: Best Practices for Travel Vaccines in the Pharmacy Setting

Pneumococcal Vaccine Patient Education: What Pharmacists Should Know and Share

ACIP Panel Removal Sparks Concerns, Pharmacists Warn of More Vaccine Distrust

As its cancer vaccine moves through the clinic, Transgene sets sights on manufacturing

Flu Vaccines Are a Go

COVID-19 Pandemic Reduced Gaps in Pneumococcal Vaccination in Medicare Enrollees, But Lowered Overall Uptake

Sanofi $1.6 billion acquisition to advance respiratory vaccines

Expanding Pneumococcal Vaccinations to Healthy Adults Aged 50 to 64 Years Offers Significant Health, Economic Benefits

Ovagen breakthrough boosts yellow fever vaccine yields

Bharat Biotech acquires licence for GSK’s Shigella vaccine development

Osivax reaches key milestone in phase 2a trial for broad-spectrum flu vaccine

Osivax publishes phase 2a results supporting dual flu vaccine approach

Small Guillain-Barré risk after RSV vaccination in older adults, warns MHRA

FDA Approves GSK’s Shingles Vaccine in Prefilled Syringe

Q&A: Pharmacies Grapple With Patient Influx Amid Rite Aid Closures

Conference Coverage Recap: American Pharmacists Association Annual Meeting and Exposition 2025

DoH – Abu Dhabi and Sanofi link for vaccine development

Insights From ASCO 2025 Guide Pharmacy Practice in Solid Tumors and Hematologic Cancers

ACIP Votes Against Thimerosal Vaccines for Prevention of Influenza

Pharmacists Can Simplify the Vaccine Schedule

Efficiency, Education, and Evolution: What’s Next for Pharmacy Practice?

Shaping Pharmacy Research With Purpose and Public Impact

PharmaShots Weekly Snapshots (Jun 09, 2025 – Jun 13, 2025)

Q&A: Supporting Pharmacy Technicians Through Daily Recognition

Independent Pharmacy Innovation Spotlighted at McKesson ideaShare 2025

FDA Approves Vancomycin Injection For Ready-to-Infuse Sepsis Therapy

Pharmacists Help Patients Manage Chronic Pain

Pharmacist-Led Interventions Show Promise in Improving COPD Outcomes

Inside the Synergy Between HOPA and OPC’s Evolving Educational Impact

Dapagliflozin Improves Health Outcomes for Adolescents With Type 1 Diabetes

Pharmacists Push Forward: Innovative Clinical Solutions Highlighted at McKesson ideaShare 2025

Pharmacists Reimagine Myeloma Care With Insights from ASCO

FDA Moving to Nonanimal Testing Methodologies in Preclinical Research

The Changing Landscape of Pharmacy Accessibility

Creating Space for Pharmacy Technicians to Lead and Thrive

New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma

Neoadjuvant Nivolumab With Chemotherapy Yields Significant Overall Survival Benefit in Resectable NSCLC

Under the Weather: Unpacking the Impact of the 2024-2025 Influenza Season

Q&A: How ACIP Changes Could Reshape Patient Care

ICH Q6B for Analytics

Supporting the Well-Being of Community Pharmacy Technicians

Stay Connected

PharmaShots Weekly Snapshots (Jun 09, 2025 – Jun 13, 2025) 